1. Home
  2. BCTXL vs PGYWW Comparison

BCTXL vs PGYWW Comparison

Compare BCTXL & PGYWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BriaCell Therapeutics Corp. Warrant expiring 2031

BCTXL

BriaCell Therapeutics Corp. Warrant expiring 2031

N/A

Current Price

$0.65

Market Cap

0.0

Sector

N/A

ML Signal

N/A

Logo Pagaya Technologies Ltd.

PGYWW

Pagaya Technologies Ltd.

N/A

Current Price

$0.05

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BCTXL
PGYWW
Founded
N/A
2016
Country
Canada
United States
Employees
4
511
Industry
Finance: Consumer Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BCTXL
PGYWW
Price
$0.65
$0.05
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
19.1K
79.4K
Earning Date
N/A
02-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,032,248,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
27.12
52 Week Low
$0.63
$0.03
52 Week High
$1.40
$0.72

Technical Indicators

Market Signals
Indicator
BCTXL
PGYWW
Relative Strength Index (RSI) 39.97 43.17
Support Level N/A $0.03
Resistance Level $1.25 $0.06
Average True Range (ATR) 0.07 0.01
MACD -0.01 -0.00
Stochastic Oscillator 32.35 39.37

Price Performance

Historical Comparison
BCTXL
PGYWW

About BCTXL BriaCell Therapeutics Corp. Warrant expiring 2031

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

About PGYWW Pagaya Technologies Ltd.

Pagaya Technologies Ltd is a product-focused technology company. It uses machine learning, a vast data network, and an AI-driven approach to offer comprehensive consumer credit and residential real estate products for its partners, their customers, and investors. Its suite of products includes Decline Monetization, Dual Look, First Look, Affiliate Optimizer Engine, Direct Marketing Engine, and FastPass, providing lenders with an AI-powered credit and acquisition ecosystem that helps them approve more borrowers, capture more demand, and grow without adding risk. Geographically, the company generates maximum revenue from its business in the United States.

Share on Social Networks: